Additional file 3: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion
- Hanan Elsarraj (3557555)
- Yan Hong (80440)
- Kelli Valdez (3557546)
- Whitney Michaels (3557525)
- Marcus Hook (3557552)
- William Smith (517181)
- Jeremy Chien (185202)
- Jason Herschkowitz (3557564)
- Melissa Troester (3403661)
- Moriah Beck (3557549)
- Marc Inciardi (3557537)
- Jason Gatewood (3557528)
- Lisa May (3557561)
- Therese Cusick (3557531)
- Marilee McGinness (3557543)
- Lawrence Ricci (3557534)
- Fang Fan (334244)
- Ossama Tawfik (276135)
- Jeffrey Marks (711578)
- Jennifer Knapp (3432767)
- Hung-Wen Yeh (3557558)
- Patricia Thomas (3489989)
- D. Carrasco (3557540)
- Timothy Fields (3557567)
- Andrew Godwin (811543)
- Fariba Behbod (3505388)
Publication date
September 2015
DOIAbstract
Differentially expressed genes in DCIS.COM and SUM225 mouse intraductal xenograft model (MIND) xenografts during transition from 2 to 6 weeks. Significance analysis for microarrays (SAM) software was utilized to determine differentially expressed genes between the 2- to 6-week time point in both DCIS.COM and SUM225 cell lines. The cutoff for significance was determined by <5 % false discovery rate. Two-class unpaired SAM analysis generated a list of significant genes and fold-change values between 2 and 6 weeks in DCIS.COM (18,590 downregulated; 10,227 upregulated) and SUM225 (19,953 downregulated and 14,691 upregulated). (XLSX 3297 kb
Add to ORKG